Joe Biden to meet baby food and supplement makers over supply crunch

US President Joe Biden is set to meet with infant formula manufacturers as his administration works to ease nationwide shortages by importing foreign supplies

Joe Biden
US President Joe Biden (Photo: Reuters)
AP Washington
2 min read Last Updated : Jun 01 2022 | 4:06 PM IST

US President Joe Biden is set to meet with infant formula manufacturers as his administration works to ease nationwide shortages by importing foreign supplies and using the Defense Production Act to speed domestic production.

The White House said Biden would host a roundtable on Wednesday with leaders of manufacturers ByHeart, Bubs Australia, Reckitt, Perrigo Co. and Gerber.

The list is notable for who isn't on it: Abbott Nutrition, the company whose Michigan plant was shut down in February over safety concerns, sparking the shortage in the US.

Biden will be joined by Heath and Human Services Secretary Xavier Becerra and Surgeon General Vivek Murthy.

The meeting is expected to provide an update on what the administration has dubbed Operation Fly Formula to import formula from overseas into the US and deploy the Korean War-era production law to require suppliers of the formula manufacturers to prioritise their orders in a bid to ease any production bottlenecks.

Those measures will help but won't immediately bring an end to formula supply shortages that have left people who depend on formula facing empty shelves or limits on purchases.

The Food and Drug Administration began honing in on Abbott's plant last fall while tracking several bacterial infections in infants who had consumed formula from the facility. The four cases occurred between September and January, causing hospitalisations and two deaths.

After detecting positive samples of rare but dangerous bacteria in multiple parts of the plant, the FDA closed the facility and Abbott announced a massive recall of its formula on February 17.

US regulators and Abbott announced an agreement last month that would help pave the way for reopening the plant, though production has not restarted.

The White House did not respond to a request for comment on why Abbott was not included in Wednesday's meeting.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Joe Bidendrug manufacturersSupply chain

First Published: Jun 01 2022 | 4:05 PM IST

Next Story